Power Solutions (PSIX) Director Sells 5,000 RSA Shares on Nasdaq

Rhea-AI Filing Summary

Power Solutions International (PSIX) reports a Form 144 filing indicating a proposed sale of 5,000 shares of Common Stock through Merrill Lynch on Nasdaq with an aggregate market value of $474,274.88. The filing lists total shares outstanding as 40,000, so the proposed sale equals 12.5% of the outstanding shares.

The shares were acquired on 07/10/2025 via a restricted stock award (RSA) from Power Solutions International as director compensation and were paid on the same date. The filer reports no securities sold in the past three months and makes the standard representation that they are not aware of undisclosed material adverse information.

Positive

• Clear disclosure of the proposed sale including broker, date, and aggregate market value demonstrates procedural compliance
• No reported sales in the prior three months, indicating this filing is not part of a recent pattern of dispositions

Negative

• Large disposition relative to outstanding shares: 5,000 shares represent 12.5% of the reported 40,000 shares outstanding
• Short interval between grant and proposed sale: shares were acquired on 07/10/2025 and are planned to be sold on 08/12/2025, about one month later

Insights

Financial Analyst

TL;DR: Director granted RSA shares files Form 144 to sell 5,000 shares (12.5% of outstanding), a potentially material insider disposition.

The filing shows a proposed sale of 5,000 common shares valued at $474,274.88 through Merrill Lynch on Nasdaq, compared with 40,000 shares outstanding. A sale representing 12.5% of outstanding stock is large relative to the stated float and could affect short-term supply and pricing dynamics. The shares were acquired as director compensation on 07/10/2025 via an RSA and there were no reported sales in the prior three months, indicating this is a newly planned disposition rather than part of a pattern disclosed here.

Corporate Governance Expert

TL;DR: Transaction follows compensation issuance and is disclosed under Rule 144; the filing provides standard attestations and broker details.

The record shows the securities were issued as director compensation and the filer has complied with Form 144 disclosure requirements, naming Merrill Lynch as broker and providing the planned sale date of 08/12/2025. The form includes the statutory representation about material nonpublic information and reports no sales in the prior three months, which supports procedural compliance. The short interval between grant (07/10/2025) and proposed sale (08/12/2025) may raise governance questions but is presented factually here without further detail.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 2 Pickwick Plaza 4th Floor Greenwich CT 06830	5000	474274.88	40000	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/10/2025	RSA	Power Solutions International			5000	07/10/2025	Director Compensation in RSA Shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the PSIX Form 144 disclose about the proposed sale?

The Form 144 reports a proposed sale of 5,000 common shares on 08/12/2025 through Merrill Lynch on Nasdaq with an aggregate market value of $474,274.88.

How were the shares acquired that are being sold under Form 144 for PSIX?

The shares were acquired on 07/10/2025 via an RSA (restricted stock award) from Power Solutions International as director compensation and paid on the same date.

What portion of PSIX outstanding stock does the proposed sale represent?

The filing lists 40,000 shares outstanding; the proposed sale of 5,000 shares equals 12.5% of that amount.

Has the filer sold any PSIX securities in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed PSIX sale?

The broker named is Merrill Lynch with an address listed at 2 Pickwick Plaza, 4th Floor, Greenwich, CT 06830.